. European-stroke-organisation, M. Tendera, V. Aboyans, M. Bartelink, I. Baumgartner et al., ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC), European Heart Journal, vol.32, issue.22, pp.2851-2906, 2011.
DOI : 10.1093/eurheartj/ehr211

N. Cailleux, H. Levesque, P. Gilbert, P. Joly, P. Lauret et al., [Digital necrosis of the arm excluding scleroderma. Retrospective study of 45 cases], Journal des Maladies Vasculaires, vol.19, pp.22-26, 1994.

R. Mclafferty, J. Edwards, L. Taylor, and J. Porter, Diagnosis and long-term clinical outcome in patients diagnosed with hand ischemia, Journal of Vascular Surgery, vol.22, issue.4, pp.361-368, 1995.
DOI : 10.1016/S0741-5214(95)70003-X

X. Papon, M. Eudo, C. Brillu, F. Villapadierna, J. Picquet et al., Severe and distal ischemia of the upper limb. Results of a surgical follow-up of 11 years in 34 patients], Journal des Maladies Vasculaires, vol.24, pp.368-372, 2013.

O. Dag, M. Kayg?n, and B. Erkut, Analysis of Risk Factors for Amputation in 822 Cases with Acute Arterial Emboli, The Scientific World Journal, vol.122, issue.2, p.673483, 2012.
DOI : 10.1007/s004230100224

L. Norgren, W. Hiatt, J. Dormandy, M. Nehler, K. Harris et al., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), pp.1-75, 2007.

J. Deguara, T. Ali, B. Modarai, and K. Burnand, Upper Limb Ischemia: 20 Years Experience from a Single Center, Vascular, vol.23, issue.2, pp.84-91, 2005.
DOI : 10.1258/rsmvasc.13.2.84

T. Hernandez-richter, M. Angele, T. Helmberger, K. Jauch, L. Lauterjung et al., Acute ischemia of the upper extremity: long-term results following thrombembolectomy with the Fogarty catheter, Langenbeck???s Archives of Surgery, vol.386, issue.4, pp.261-266, 2001.
DOI : 10.1007/s004230100224

J. Holleman, J. Hardy, J. Williamson, S. Raju, and W. Neely, Arterial Surgery for Arm Ischemia A Survey of 136 Patients, Annals of Surgery, vol.191, issue.6, pp.727-737, 1980.
DOI : 10.1097/00000658-198006000-00011

P. Licht, B. T. , W. B. Baudier, J. Røder, and O. , Long-term Outcome Following Thrombembolectomy in the Upper Extremity, European Journal of Vascular and Endovascular Surgery, vol.28, issue.5, pp.508-512, 2004.
DOI : 10.1016/j.ejvs.2004.08.007

J. Kretz, E. Weiss, A. Limuris, B. Eisenmann, D. Greff et al., Arterial emboli of the upper extremity: a persisting problem, Savelyev VS, Zatevakhin II, Stepanov NV. Artery embolism of the upper limbs, pp.233-235367, 1977.

S. Sultan, D. Evoy, A. Eldin, M. Eldeeb, and N. Elmehairy, Atraumatic acute upper limb ischemia: a series of 64 patients in a Middle East tertiary vascular center and literature review 14. d'Addato M, Pedrini L. [Non-cardiac causes of acute ischemia in the arms], Vasc Surg. Journal des Maladies Vasculaires, vol.35, issue.21, pp.181-197303, 1996.

C. Granger, J. Alexander, J. Mcmurray, R. Lopes, E. Hylek et al., Apixaban versus Warfarin in Patients with Atrial Fibrillation, Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation, pp.981-992, 2011.
DOI : 10.1056/NEJMoa1107039

S. Connolly, J. Eikelboom, C. Joyner, H. Diener, R. Hart et al., Apixaban in Patients with Atrial Fibrillation, AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation, pp.806-817, 2011.
DOI : 10.1056/NEJMoa1007432

M. Vayssairat, J. Fiessinger, and E. Housset, Digital necroses of the upper limb. 86 cases], Nouv Presse Med, vol.6, pp.931-934, 1977.

M. Vayssairat, C. Debure, J. Cormier, P. Bruneval, C. Laurian et al., Hypothenar hammer syndrome: Seventeen cases with long-term follow-up, Journal of Vascular Surgery, vol.5, issue.6, pp.838-843, 1987.
DOI : 10.1016/0741-5214(87)90096-6

I. Marie, F. Hervé, E. Primard, N. Cailleux, and H. Lévesque, Long-Term Follow-Up of Hypothenar Hammer Syndrome, Medicine, vol.86, issue.6, pp.334-343, 2007.
DOI : 10.1097/MD.0b013e31815c95d3

M. Abdallah, S. Hamzaoui, T. Larbi, K. Bouslama, A. Harmel et al., Profil ??tiologique des n??croses digitales des membres sup??rieurs??: analyse de 25??observations, Journal des Maladies Vasculaires, vol.35, issue.1, pp.12-16, 2010.
DOI : 10.1016/j.jmv.2009.11.001

S. Todesco and G. Tirri, Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients, Medicine, vol.81, pp.139-153, 2002.

W. Campbell, B. Ridler, and T. Szymanska, Current management of acute leg ischaemia: results of an audit by the Vascular Surgical Society of Great Britain and Ireland, British Journal of Surgery, vol.80, issue.11, pp.1498-1503, 1998.
DOI : 10.1046/j.1365-2168.1998.00906.x

D. Bhatt, P. Steg, E. Ohman, A. Hirsch, Y. Ikeda et al., International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis, JAMA, vol.295, issue.2, pp.180-189, 2006.
DOI : 10.1001/jama.295.2.180

E. Pe-investigators, H. Büller, M. Prins, A. Lensin, H. Decousus et al., Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism, New England Journal of Medicine, vol.366, issue.14, pp.1287-1297, 2012.
DOI : 10.1056/NEJMoa1113572

E. Investigators, R. Bauersachs, S. Berkowitz, B. Brenner, H. Büller et al., Oral rivaroxaban for symptomatic venous thromboembolism, N Engl J Med, vol.363, pp.2499-2510, 2010.

M. Charakida, S. Masi, T. Lüscher, J. Kastelein, and J. Deanfield, Assessment of atherosclerosis: the role of flow-mediated dilatation, European Heart Journal, vol.31, issue.23, pp.2854-2861, 2010.
DOI : 10.1093/eurheartj/ehq340

P. Ames, J. Nourooz-zadeh, C. Tommasino, J. Alves, V. Brancaccio et al., Oxidative stress in primary antiphospholipid syndrome, Blood Coagulation & Fibrinolysis, vol.8, issue.7, pp.447-449, 1998.
DOI : 10.1097/00001721-199710000-00038

J. Delgado-alves, P. Ames, S. Donohue, L. Stanyer, J. Nourooz-zadeh et al., Antibodies to high-density lipoprotein and ?2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome, Arthritis & Rheumatism, vol.69, issue.10, pp.2686-2694, 2002.
DOI : 10.1002/art.10542

J. Aviña-zubieta, H. Choi, M. Sadatsafavi, M. Etminan, J. Esdaile et al., Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies, Arthritis & Rheumatism, vol.50, issue.12, pp.1690-1697, 2008.
DOI : 10.1002/art.24092

R. Von and S. , Ein fall von in der arteria ulnaris einwirkung von stumpfer gewalt, Acta chir scand, 1934.

B. Ferris, L. Taylor, K. Oyama, R. Mclafferty, J. Edwards et al., Hypothenar hammer syndrome: Proposed etiology, Journal of Vascular Surgery, vol.31, issue.1, pp.104-113, 2000.
DOI : 10.1016/S0741-5214(00)70072-3

URL : http://doi.org/10.1016/s0741-5214(00)70072-3

!. Odén, A. Fahlén, M. Hart, and R. , Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal, Thrombosis Research, vol.117, issue.5, pp.493-499, 2006.
DOI : 10.1016/j.thromres.2004.11.025

Y. Zeng, M. Li, D. Xu, Y. Hou, Q. Wang et al., Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity, Clin. Exp. Rheumatol, vol.30, pp.76-80, 2012.

D. Melliere, Y. Castier, J. Becquemin, A. Cavillon, and P. Desgranges, Severe limb ischemia due to iatrogenic trauma], Journal des Maladies Vasculaires, vol.21, pp.141-147, 1996.

P. Stella, F. Kiemeneij, G. Laarman, D. Odekerken, T. Slagboom et al., Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty, Catheterization and Cardiovascular Diagnosis, vol.16, issue.2, pp.156-158, 1997.
DOI : 10.1002/(SICI)1097-0304(199702)40:2<156::AID-CCD7>3.0.CO;2-A

P. Coughlin and A. Mavor, Arterial Consequences of Recreational Drug Use, European Journal of Vascular and Endovascular Surgery, vol.32, issue.4, pp.389-396, 2006.
DOI : 10.1016/j.ejvs.2006.03.003

F. Cormier, F. Korso, J. Fichelle, C. Gautier, and J. Cormier, [Post-irradiation axillosubclavian arteriopathy: surgical revascularization], Journal des Maladies Vasculaires, vol.26, pp.45-49, 2001.

J. Journet, H. Bui, C. Capdevila, S. Lavaud, H. Henni et al., Isch??mie digitale par embolie ?? partir d???un abord d???h??modialyse thrombos????: une complication rare ?? ne pas m??conna??tre, N??phrologie & Th??rapeutique, vol.6, issue.2, pp.121-124, 2010.
DOI : 10.1016/j.nephro.2009.12.002

L. Benson, A. Bare, D. Nagle, V. Harder, C. Williams et al., Complications of Endoscopic and Open Carpal Tunnel Release, Arthroscopy: The Journal of Arthroscopic & Related Surgery, vol.22, issue.9, pp.919-943, 2006.
DOI : 10.1016/j.arthro.2006.05.008

R. Jl and J. Cabane, Buerger's disease or thromboangiitis obliterans]. La Revue de Médecine Interne, pp.34-43, 1998.

S. Sasaki, M. Sakuma, T. Kunihara, and K. Yasuda, Current trends in thromboangiitis obliterans (buerger???s disease) in women, The American Journal of Surgery, vol.177, issue.4, pp.316-320, 1999.
DOI : 10.1016/S0002-9610(99)00046-X

J. Fiessinger and M. Schäfer, Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans, The Lancet, vol.335, issue.8689, pp.555-557, 1990.
DOI : 10.1016/0140-6736(90)90346-7

J. Blom, C. Doggen, S. Osanto, and F. Rosendaal, Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis, JAMA, vol.293, issue.6, pp.715-722, 2005.
DOI : 10.1001/jama.293.6.715

A. Khorana, C. Francis, N. Blumberg, E. Culakova, M. Refaai et al., Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer, Archives of Internal Medicine, vol.168, issue.21, pp.2377-2381, 2008.
DOI : 10.1001/archinte.168.21.2377

V. Caruso, D. Castelnuovo, A. Meschengieser, S. Lazzari, M. De-gaetano et al., Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events, Blood, vol.115, issue.26, pp.5322-5328, 2010.
DOI : 10.1182/blood-2010-01-258624

S. El, K. Gambhir, R. Halawa, M. Chong, P. Rashid et al., Association of malignant disease with critical leg ischaemia, Br J Surg, vol.92, pp.1498-1501, 2005.

M. Javid, T. Magee, and R. Galland, Arterial Thrombosis Associated with Malignant Disease, European Journal of Vascular and Endovascular Surgery, vol.35, issue.1, pp.84-87, 2008.
DOI : 10.1016/j.ejvs.2007.08.014

S. Blaise, H. Appeltants, P. Carpentier, and J. Debru, Isch??mie digitale et gemcitabine, Journal des Maladies Vasculaires, vol.30, issue.1, pp.53-57, 2005.
DOI : 10.1016/S0398-0499(05)83795-3

T. Proverbs-singh, S. Chiu, Z. Liu, S. Seng, G. Sonpavde et al., Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis, JNCI Journal of the National Cancer Institute, vol.104, issue.23, pp.1837-1840, 2012.
DOI : 10.1093/jnci/djs435

A. Varki, Trousseau's syndrome: multiple definitions and multiple mechanisms, Blood, vol.110, issue.6, pp.1723-1729, 2007.
DOI : 10.1182/blood-2006-10-053736

R. Cervera, J. Piette, J. Font, M. Khamashta, Y. Shoenfeld et al., Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis & Rheumatism, vol.15, issue.suppl 7, pp.1019-1027, 2002.
DOI : 10.1002/art.10187

Z. Ye, E. Liu, J. Higgins, B. Keavney, G. Lowe et al., Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66???155 cases and 91???307 controls, The Lancet, vol.367, issue.9511, pp.651-658, 2006.
DOI : 10.1016/S0140-6736(06)68263-9

R. Jl, M. Alhenc-gelas, F. P. Bissery, A. Julia, P. Fiessinger et al., The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study, J Thromb Haemost, vol.2, pp.1334-1340, 2004.

M. Vasse, Protein Z, a protein seeking a pathology, Thrombosis and Haemostasis, vol.100, pp.548-556, 2008.
DOI : 10.1160/TH08-01-0024

M. Heeb, A. Paganini-hill, J. Griffin, and M. Fisher, Low Protein Z Levels and Risk of Ischemic Stroke: Differences by Diabetic Status and Gender, Blood Cells, Molecules, and Diseases, vol.29, issue.2, pp.139-144, 2002.
DOI : 10.1006/bcmd.2002.0549

J. Staton, M. Sayer, G. Hankey, V. Cole, J. Thom et al., Protein Z Gene Polymorphisms, Protein Z Concentrations, and Ischemic Stroke, Stroke, vol.36, issue.6, pp.1123-1127, 2005.
DOI : 10.1161/01.STR.0000166058.49577.ca

M. Vasse, E. Guegan-massardier, J. Borg, F. Woimant, and C. Soria, Frequency of protein Z deficiency in patients with ischaemic stroke, The Lancet, vol.357, issue.9260, pp.933-934, 2001.
DOI : 10.1016/S0140-6736(00)04218-5

F. Sofi, F. Cesari, S. Vigiani, C. Fatini, R. Marcucci et al., Protein Z plasma levels in different phases of activity of coronary atherosclerosis, Journal of Thrombosis and Haemostasis, vol.2, issue.10, pp.2254-2258, 2005.
DOI : 10.1111/j.1538-7836.2005.01536.x

F. Sofi, F. Cesari, R. Marcucci, C. Fatini, A. Gori et al., Protein Z levels and prognosis in patients with acute coronary syndromes, Clinical Chemical Laboratory Medicine, vol.44, issue.9, pp.1098-1102, 2006.
DOI : 10.1515/CCLM.2006.206

S. Fedi, F. Sofi, D. Brogi, I. Tellini, F. Cesari et al., Low Protein Z plasma levels are independently associated with acute coronary syndromes, Thrombosis and Haemostasis, vol.90, pp.1173-1178, 2003.
DOI : 10.1160/TH03-04-0237

F. Sofi, F. Cesari, G. Pratesi, A. Cellai, R. Pulli et al., Low protein Z levels in patients with peripheral arterial disease, Thrombosis and Haemostasis, vol.98, pp.1114-1117, 2007.
DOI : 10.1160/TH07-04-0300

J. Pardos-gea, J. Ordi-ros, S. Serrano, E. Balada, I. Nicolau et al., Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis, Thrombosis Research, vol.121, issue.6, pp.727-734, 2008.
DOI : 10.1016/j.thromres.2007.07.009

I. Martinelli, C. Razzari, E. Biguzzi, P. Bucciarelli, and P. Mannucci, Low levels of protein Z and the risk of venous thromboembolism, Journal of Thrombosis and Haemostasis, vol.17, issue.12, pp.2817-2819, 2005.
DOI : 10.1182/blood.V99.8.2720

Y. Desai and J. Robbs, Arterial complications of the thoracic outlet syndrome, European Journal of Vascular and Endovascular Surgery, vol.10, issue.3, pp.362-365, 1995.
DOI : 10.1016/S1078-5884(05)80058-9

J. Durham, J. Yao, W. Pearce, G. Nuber, and W. Mccarthy, Arterial injuries in the thoracic outlet syndrome, Journal of Vascular Surgery, vol.21, issue.1, pp.57-69, 1995.
DOI : 10.1016/S0741-5214(95)70244-X

J. Gillard, M. Pérez-cousin, E. Hachulla, R. J. Hurtevent, J. Vinckier et al., Diagnosing thoracic outlet syndrome: contribution of provocative tests, ultrasonography, electrophysiology, and helical computed tomography in 48 patients, Joint Bone Spine, vol.68, issue.5, pp.416-424, 2001.
DOI : 10.1016/S1297-319X(01)00298-6

A. Aburahma, B. Richmond, and P. Robinson, Etiology of peripheral arterial thromboembolism in young patients, The American Journal of Surgery, vol.176, issue.2, pp.158-161, 1998.
DOI : 10.1016/S0002-9610(98)00160-3

C. Dao and J. Tobis, PFO and paradoxical embolism producing events other than stroke, Catheterization and Cardiovascular Interventions, vol.357, issue.6, pp.903-909, 2011.
DOI : 10.1002/ccd.22884

G. Rigatelli, M. Giordan, G. Braggion, S. Aggio, M. Chinaglia et al., Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts, Cardiovascular Revascularization Medicine, vol.8, issue.4, pp.248-250, 2007.
DOI : 10.1016/j.carrev.2007.03.001

P. Hagen, D. Scholz, and W. Edwards, Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 965 Normal Hearts, Mayo Clinic Proceedings, vol.59, issue.1, pp.17-20, 1984.
DOI : 10.1016/S0025-6196(12)60336-X

!. Xw-!-76, A. Furlan, M. Reisman, J. Massaro, L. Mauri et al., Closure or medical therapy for cryptogenic stroke with patent foramen ovale, N Engl J Med, vol.366, pp.991-999, 2012.

J. Carroll, J. Saver, D. Thaler, R. Smalling, S. Berry et al., Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke, New England Journal of Medicine, vol.368, issue.12, pp.1092-1100, 2013.
DOI : 10.1056/NEJMoa1301440

B. Meier, B. Kalesan, H. Mattle, A. Khattab, D. Hildick-smith et al., Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism, New England Journal of Medicine, vol.368, issue.12, pp.1083-1091, 2013.
DOI : 10.1056/NEJMoa1211716

T. Mirault and J. Emmerich, Maladie de Takayasu. Comment la prendre en charge???, La Presse M??dicale, vol.41, issue.10, pp.975-985, 2012.
DOI : 10.1016/j.lpm.2012.07.010

T. Quemeneur, E. Hachulla, M. Lambert, M. Perez-cousin, V. Queyrel et al., Maladie de Takayasu, La Presse M??dicale, vol.35, issue.5, pp.847-856, 2006.
DOI : 10.1016/S0755-4982(06)74703-0

G. Kerr, C. Hallahan, J. Giordano, R. Leavitt, A. Fauci et al., Takayasu Arteritis, Annals of Internal Medicine, vol.120, issue.11, pp.919-929, 1994.
DOI : 10.7326/0003-4819-120-11-199406010-00004

R. Subramanyan, J. Joy, and K. Balakrishnan, Natural history of aortoarteritis (Takayasu's disease), Circulation, vol.80, issue.3, pp.429-437, 1989.
DOI : 10.1161/01.CIR.80.3.429

C. Salvarani, S. Gabriel, O. Fallon, W. Hunder, and G. , The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern, Annals of Internal Medicine, vol.123, issue.3, pp.192-194, 1995.
DOI : 10.7326/0003-4819-123-3-199508010-00006

M. Gonzalez-gay, T. Vazquez-rodriguez, M. Lopez-diaz, J. Miranda-filloy, C. Gonzalez-juanatey et al., Epidemiology of giant cell arteritis and polymyalgia rheumatica, Arthritis & Rheumatism, vol.29, issue.10, pp.1454-1461, 2009.
DOI : 10.1002/art.24459

C. Assie, A. Janvresse, D. Plissonnier, H. Lévesque, and M. I. , Long-Term Follow-Up of Upper and Lower Extremity Vasculitis Related to Giant Cell Arteritis, Medicine, vol.90, issue.1, pp.40-51, 2011.
DOI : 10.1097/MD.0b013e318206af16

J. Kiladjian, F. Cervantes, F. Leebeek, C. Marzac, B. Cassinat et al., The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases, Blood, vol.111, issue.10, pp.4922-4929, 2008.
DOI : 10.1182/blood-2007-11-125328

J. Reiffel, R. Schwarzberg, and M. Murry, Comparison of Autotriggered Memory Loop Recorders Versus Standard Loop Recorders Versus 24-Hour Holter Monitors for Arrhythmia Detection, The American Journal of Cardiology, vol.95, issue.9, pp.1055-1059, 2005.
DOI : 10.1016/j.amjcard.2005.01.025

J. Emmerich, Maladies des vaisseaux, 1998.

T. Loosemore, T. Chalmers, and J. Dormandy, A meta-analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease, Int Angiol, vol.13, pp.133-142, 1994.

A. Hirsch, Z. Haskal, N. Hertzer, C. Bakal, M. Creager et al., American Association for Vascular Surgery, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, ACC/AHA Task Force on Practice Guidelines, American Association of Cardiovascular and Pulmonary Rehabilitation Society for Vascular Nursing, TransAtlantic Inter- Society Consensus, Vascular Disease Foundation. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute, pp.1239-1312, 2006.

M. Rademaker, E. Cooke, N. Almond, J. Beacham, R. Smith et al., Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study., BMJ, vol.298, issue.6673, pp.561-564, 1989.
DOI : 10.1136/bmj.298.6673.561

M. Mozes, G. Cahansky, V. Doitsch, and R. Adar, The association of atherosclerosis and Buerger's disease: a clinical and radiological study, J Cardiovasc Surg (Torino), vol.11, pp.52-59, 1970.

J. Olin, Thromboangiitis Obliterans (Buerger's Disease), New England Journal of Medicine, vol.343, issue.12, pp.864-869, 2000.
DOI : 10.1056/NEJM200009213431207

J. Fiessinger, S. Tawfik-taher, L. Capron, C. Laurian, J. Cormier et al., Takayasu " s disease. Diagnostic criteria (author " s transl)], Nouv Presse Med, vol.11, pp.583-586, 1982.

W. Arend, B. Michel, D. Bloch, G. Hunder, L. Calabrese et al., The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis, Arthritis & Rheumatism, vol.33, issue.8, pp.1129-1134, 1990.
DOI : 10.1002/art.1780330811

!. Xy-!-97, G. Hunder, D. Bloch, B. Michel, M. Stevens et al., The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum, vol.33, pp.1122-1128, 1990.

S. Miyakis, M. Lockshin, T. Atsumi, D. Branch, R. Brey et al., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), Journal of Thrombosis and Haemostasis, vol.75, issue.2, pp.295-306, 2006.
DOI : 10.1080/00313020310001643615

E. Leroy and T. Medsger, Criteria for the classification of early systemic sclerosis, J. Rheumatol, vol.28, pp.1573-1576, 2001.

F. Netter, Atlas of Human Anatomy, 2010.